Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Alterity Therapeutics's pe ratio was 69.7× on Aug 30, 2024, against 66.6× a year earlier. Over the last 5 years it ranged from 0.7× to 69.7×, with a median of 2.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Aug 30, 2024 | 69.7× | +16.0 |
| 2023 | Dec 29, 2023 | 53.7× | +52.1 |
| 2022 | Dec 30, 2022 | 1.6× | −0.7 |
| 2021 | Dec 31, 2021 | 2.3× | +0.3 |
| 2020 | Dec 31, 2020 | 1.9× | +1.0 |
| 2019 | Dec 31, 2019 | 0.9× | – |
See a number that looks wrong?